Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yanagihara, T.
Right arrow Articles by Wahner, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yanagihara, T.
Right arrow Articles by Wahner, H. W.

Stroke, Vol 15, 816-822, Copyright © 1984 by American Heart Association


ARTICLES

Cerebral blood flow measurement in cerebrovascular occlusive diseases

T Yanagihara and HW Wahner

In order to evaluate cerebral blood flow (CBF) patterns among individual patients with increased statistical confidence, CBF measurements were carried out using the 133Xe-inhalation method and external head detectors. F1 values representing gray matter flow from 3 to 6 head detectors were averaged to form 16 different regions for each cerebral hemisphere. Normative values were obtained from 46 healthy volunteers, and data from individual regions were analyzed for absolute blood flow rates (ml/100g/min), for concordance between right and left hemispheres and as percent of mean hemispheric flow. CBF measurements were then carried out among 37 patients with cerebrovascular occlusive diseases, and results were compared with normative values. A high incidence of abnormal flows were detected among symptomatic patients with intracranial arterial stenosis or occlusion and those with extracranial internal carotid artery occlusion. By using the above method for data analysis, it was possible to delineate hypoperfused areas among these patients. Even though the 133Xe-inhalation method has inherent limitations, this is a practical and safe method for measurement of CBF which can provide reliable information useful for management of patients with cerebrovascular occlusive diseases, particularly when the results are presented with statistical confidence.


This article has been cited by other articles:


Home page
StrokeHome page
P. Scheel, C. Ruge, U. R. Petruch, and M. Schoning
Color Duplex Measurement of Cerebral Blood Flow Volume in Healthy Adults
Stroke, January 1, 2000; 31(1): 147 - 150.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
R. L. Levine, J. M. Rozental, and R. J. Nickles
Blood Flow Asymmetry in Carotid Occlusive Disease
Angiology, February 1, 1992; 43(2): 100 - 109.
[Abstract] [PDF]


Home page
Vasc MedHome page
D. C. Costa
Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool
Vascular Medicine, September 1, 1990; 1(2): 179 - 201.
[PDF]